Expects High-Single-Digit Annual Net Revenue Growth and Annual Adjusted Operating Margin 1 Expansion of 50 to 150 Basis Points Through Fiscal 2030 Provides Planning Scenario of High-Single-Digit Net ...
Scribe Therapeutics Inc. (“Scribe”), a genetic medicines company pioneering next-generation in vivo CRISPR-based medicines designed to be safe, durable, and effective enough to become standard-of-care ...
National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will host an Investor Day at NASDAQ MarketSite in New York City today to detail its comprehensive transformation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback